BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Somayyeh Asghari, Maryam Rafraf, Laleh Farzin, Mohammad Asghari-Jafarabadi, Seyed-Mostafa Ghavami, Mohammad-Hossein Somi. Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled TrialAdvanced Pharmaceutical Bulletin 2018; 8(2): 307 doi: 10.15171/apb.2018.036
2
Xupeng Bai, Weipeng Hong, Peiheng Cai, Yibei Chen, Chuncao Xu, Di Cao, Weibang Yu, Zhongxiang Zhao, Min Huang, Jing Jin. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesisToxicology and Applied Pharmacology 2017; 324: 12 doi: 10.1016/j.taap.2017.03.022
3
Islam N. Mohamed, Nahla Reda Sarhan, Mohamed Ahmed Eladl, Azza B. El-Remessy, Mohamed El-Sherbiny. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical studyActa Histochemica 2018; 120(3): 242 doi: 10.1016/j.acthis.2018.02.006
4
Mabel Graffigna, Natalia Catoira, Jimena Soutelo, Andreína Azpelicueta, Gabriela Berg, Cecilia Perel, Marta Elena Migliano, Marcela Aranguren, Carla Musso, Javier Farias. Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenesRevista Argentina de Endocrinología y Metabolismo 2017; 54(1): 37 doi: 10.1016/j.raem.2016.12.001
5
Vanessa Souza-Mello. Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockadeWorld Journal of Hepatology 2017; 9(2): 74-79 doi: 10.4254/wjh.v9.i2.74
6
Yi Zhang, Hong An, Si-Yuan Pan, Dan-Dan Zhao, Jia-Cheng Zuo, Xiao-Ke Li, Ya Gao, Qian-Qian Mu, Na Yu, Yue Ma, Fang-Fang Mo, Si-Hua Gao. Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic MiceEvidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/1592731
7
Heibatullah Kalantari, Mohammad Javad Khodayar, Najmaldin Saki, Layasadat Khorsandi, Ali Teymoori, Hadis Alidadi, Azin Samimi. Microarray analysis of apoptosis gene expression in liver injury induced by chronic exposure to arsenic and high-fat diet in male miceEnvironmental Science and Pollution Research 2019; 26(25): 26351 doi: 10.1007/s11356-019-05907-3
8
Yuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, Volatiana Rakotoarivelo, Sakina Orkhis, Marian Mayhue, Yi-Guang Chen, Marek Rola-Pleszczynski, Alfredo Menendez, Subburaj Ilangumaran, Sheela Ramanathan. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver diseaseCytokine 2016; 82: 102 doi: 10.1016/j.cyto.2016.01.020
9
Alireza Rahmanabadi, Soltanali Mahboob, Farshad Amirkhizi, Sonya Hosseinpour-Arjmand, Mehrangiz Ebrahimi-Mameghani. Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology featuresFood & Function 2019; 10(8): 4941 doi: 10.1039/C9FO00449A
10
Cong Liu, Jia-Zhi Liao, Pei-Yuan Li. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(11): 1964-1973 doi: 10.3748/wjg.v23.i11.1964
11
V. I. Prymachenko. Changes in the Structure of the Liver during Obesity (Literature Review)Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2018; 4(2): 45 doi: 10.26693/jmbs04.02.045
12
Victoria Sid, Yue Shang, Yaw L. Siow, Susara Madduma Hewage, James D. House, Karmin O. Folic Acid Supplementation Attenuates Chronic Hepatic Inflammation in High-Fat Diet Fed MiceLipids 2018; 53(7): 709 doi: 10.1002/lipd.12084
13
XXVI Brazilian Congress on Biomedical EngineeringIFMBE Proceedings  doi: 10.1007/978-981-13-2119-1_8
14
Karen Jackson, Noa Dressler, Rotem S Ben-Shushan, Ari Meerson, Tyler W LeBaron, Snait Tamir. Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse modelWorld Journal of Gastroenterology 2018; 24(45): 5095-5108 doi: 10.3748/wjg.v24.i45.5095
15
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease associationArab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
16
Ángela Rojas, Paloma Gallego, Antonio Gil-Gómez, Rocío Muñoz-Hernández, Lourdes Rojas, Rosario Maldonado, Rocío Gallego-Durán, Marta García-Valdecasas, José A. Del Campo, Juan D. Bautista, Manuel Romero-Gómez. Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotypeAnnals of Hepatology 2018; 17(2): 242 doi: 10.5604/01.3001.0010.8642
17
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>&reg;</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
18
Nicholas J. G. Webster. Alternative RNA Splicing in the Pathogenesis of Liver DiseaseFrontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00133
19
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae, Soheyla Khakdan. High-intensity interval training (HIIT) alleviated NAFLD feature viamiR-122induction in liver of high-fat high-fructose diet induced diabetic ratsArchives of Physiology and Biochemistry 2018; : 1 doi: 10.1080/13813455.2018.1510968
20
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiotaMetabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
21
Kathryn Smedlund, Prabhatachandra Dube, Guillermo Vazquez. Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosisPhysiological Genomics 2016; 48(8): 644 doi: 10.1152/physiolgenomics.00067.2016
22
Tarana Arman, Katherine D. Lynch, Michelle L. Montonye, Michael Goedken, John D. Clarke. Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in RatsToxins 2019; 11(7): 398 doi: 10.3390/toxins11070398
23
Weaam Gouda, Esmat Ashour, Yehia Shaker, Wafaa Ezzat. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patientsGenes & Diseases 2017; 4(4): 222 doi: 10.1016/j.gendis.2017.09.002
24
Charlotte Brøns, Louise Justesen. The Human Gut-Liver-Axis in Health and Disease2019; : 65 doi: 10.1007/978-3-319-98890-0_4
25
Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese RatsNutrients 2019; 11(5): 961 doi: 10.3390/nu11050961
26
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Direct effects of thyroid hormones on hepatic lipid metabolismNature Reviews Endocrinology 2018; 14(5): 259 doi: 10.1038/nrendo.2018.10
27
方行 周. The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic Fatty LiverHans Journal of Food and Nutrition Science 2015; 4(04): 116 doi: 10.12677/HJFNS.2015.44016
28
Yuneivy Cepero-Donates, Volatiana Rakotoarivelo, Marian Mayhue, Averil Ma, Yi-Guang Chen, Sheela Ramanathan. Homeostasis of IL-15 dependent lymphocyte subsets in the liverCytokine 2016; 82: 95 doi: 10.1016/j.cyto.2015.12.012
29
Haneesha Mohan, Sydney L. Brandt, Ja Hyun Kim, Frances Wong, Mi Lai, Kacey J. Prentice, Dana Al Rijjal, Lilia Magomedova, Battsetseg Batchuluun, Elena Burdett, Alpana Bhattacharjee, Carolyn L. Cummins, Denise D. Belsham, Brian Cox, Ying Liu, Michael B. Wheeler. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasisDiabetes, Obesity and Metabolism 2019; 21(1): 61 doi: 10.1111/dom.13483
30
Idris Adewale Ahmed, Maryam Abimbola Mikail, Mohammad Rais Mustafa, Muhammad Ibrahim, Rozana Othman. Lifestyle interventions for non-alcoholic fatty liver diseaseSaudi Journal of Biological Sciences 2019;  doi: 10.1016/j.sjbs.2018.12.016
31
Katherine A. Pratte, Ann Johnson, Janette Beals, Ann Bullock, Spero M. Manson, Luohua Jiang. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention ProgramDiabetes Care 2019; 42(7): 1209 doi: 10.2337/dc18-1964
32
Martin L. Decaris, Kelvin W. Li, Claire L. Emson, Michelle Gatmaitan, Shanshan Liu, Yenny Wang, Edna Nyangau, Marc Colangelo, Thomas E. Angel, Carine Beysen, Jeffrey Cui, Carolyn Hernandez, Len Lazaro, David A. Brenner, Scott M. Turner, Marc K. Hellerstein, Rohit Loomba. Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and bloodHepatology 2017; 65(1): 78 doi: 10.1002/hep.28860
33
Maddalena Parafati, R. Jason Kirby, Sepideh Khorasanizadeh, Fraydoon Rastinejad, Siobhan Malany. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosisDisease Models & Mechanisms 2018; 11(9): dmm033530 doi: 10.1242/dmm.033530
34
Subrata Deb, Prasanth Puthanveetil, Prashant Sakharkar. A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid LevelsInternational Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/1286170
35
Herath Mudiyanselage Meththananda Herath, Iroshani Kodikara, Thilak Priyantha Weerarathna, Gayani Liyanage. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center studyDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(1): 246 doi: 10.1016/j.dsx.2018.09.002
36
Deepak Kumar, Manasi Das, Consuelo Sauceda, Lesley G. Ellies, Karina Kuo, Purva Parwal, Mehak Kaur, Lily Jih, Gautam K. Bandyopadhyay, Douglas Burton, Rohit Loomba, Olivia Osborn, Nicholas J.G. Webster. Degradation of splicing factor SRSF3 contributes to progressive liver diseaseJournal of Clinical Investigation 2019; 129(10): 4477 doi: 10.1172/JCI127374
37
Shima Dowla, Stella Aslibekyan, Amy Goss, Kevin Fontaine, Ambika P. Ashraf. Dyslipidemia is associated with pediatric nonalcoholic fatty liver diseaseJournal of Clinical Lipidology 2018; 12(4): 981 doi: 10.1016/j.jacl.2018.03.089
38
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei, Anna S. Lok. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, ChinaDigestive Diseases and Sciences 2019;  doi: 10.1007/s10620-019-05709-0
39
Abd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, Reda Elwakil, Gamal Esmat, Mohamed El Kassas, Sherief Abd-Elsalam, Shorouk Moussa. Diabetes Association with Liver Diseases: An Overview for CliniciansEndocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19(3): 274 doi: 10.2174/1871530318666181116111945
40
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
41
Andrea Gallotta, Laura Paneghetti, Viera Mrázová, Adriana Bednárová, Dáša Kružlicová, Vladimir Frecer, Stanislav Miertus, Alessandra Biasiolo, Andrea Martini, Patrizia Pontisso, Giorgio Fassina. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patientsThe International Journal of Biological Markers 2018; 33(2): 231 doi: 10.1177/1724600817753577
42
Hao Han, Fubin Qiu, Haifeng Zhao, Haiying Tang, Xiuhua Li, Dongxing Shi. Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout MiceOxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/3256241
43
Wilson Yip, Ivana Sequeira, Lindsay Plank, Sally Poppitt. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of DysglycaemiaNutrients 2017; 9(11): 1273 doi: 10.3390/nu9111273
44
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
45
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
46
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver2018; : 199 doi: 10.1016/B978-0-12-803951-9.00017-3
47
Hye Rim Jang, Hyun-Jun Park, Dongwon Kang, Hayung Chung, Myung Hee Nam, Yeonhee Lee, Jae-Hak Park, Hui-Young Lee. A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorptionExperimental & Molecular Medicine 2019; 51(8) doi: 10.1038/s12276-019-0293-4
48
Yu-Ying Xu, Juan Ge, Mo-Han Zhang, Wen-Jie Sun, Jun Zhang, Pei-Lin Yu, Yi-Fan Zheng, Jun Yang, Xin-Qiang Zhu. Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley RatsInternational Journal of Toxicology 2016; 35(6): 634 doi: 10.1177/1091581816653363
49
Siouar Bensaid, Amar Kachenoura, Nathalie Costet, Victor De Ledinghen, Julien Vergniol, Fabrice Laine, Bruno Turlin, Hugues Tariel, Lotfi Senhadji. Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2016; : 3602 doi: 10.1109/EMBC.2016.7591507
50
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHBiomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
51
Nima Motamed, Behnam Rabiee, Hossein Poustchi, Babak Dehestani, Gholam Reza Hemasi, Mahmood Reza Khonsari, Mansooreh Maadi, Fatemeh Sima Saeedian, Farhad Zamani. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseasesClinics and Research in Hepatology and Gastroenterology 2017; 41(1): 31 doi: 10.1016/j.clinre.2016.07.005
52
Yongeun Kim, Sathish Kumar Natarajan, Soonkyu Chung. Gamma-Tocotrienol Attenuates the Hepatic Inflammation and Fibrosis by Suppressing Endoplasmic Reticulum Stress in MiceMolecular Nutrition & Food Research 2018; 62(21): 1800519 doi: 10.1002/mnfr.201800519
53
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
54
Graziella Rodrigues, Andrea Janz Moreira, Silvia Bona, Elizângela Schemitt, Cláudio Augusto Marroni, Fábio Cangeri Di Naso, Alexandre Simões Dias, Thienne Rocha Pires, Jaqueline Nascimento Picada, Norma Possa Marroni. Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental ModelOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3201873
55
Juliana F. Miranda, Letícia D. Scarinci, Letícia F. Ramos, Caio M. Silva, Letícia R. Gonçalves, Priscila F. Morais, Osmar Malaspina, Karen C. M. Moraes. The modulatory effect of triclosan on the reversion of the activated phenotype of LX‐2 hepatic stellate cellsJournal of Biochemical and Molecular Toxicology 2019;  doi: 10.1002/jbt.22413
56
Maryam Vaezi, Parichehreh Yaghmaei, Nasim Hayati-Roodbari, Shiva Irani, Azadeh Ebrahim-Habibi. Citral effect in male NMRI mice nonalcoholic steatosis model: assessing biochemical and histological parameters and PPARα gene expressionBrazilian Journal of Pharmaceutical Sciences 2018; 54(3) doi: 10.1590/s2175-97902018000317596
57
Huafeng Wang, Dong Wang, Luhong Yang, Yanxia Wang, Junli Jia, Dongchen Na, Huize Chen, Yongping Luo, Chengfang Liu. Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiationInternational Immunopharmacology 2017; 42: 67 doi: 10.1016/j.intimp.2016.11.012
58
Laura Braud, Sylvain Battault, Grégory Meyer, Alessandro Nascimento, Sandrine Gaillard, Georges de Sousa, Roger Rahmani, Catherine Riva, Martine Armand, Jean-Michel Maixent, Cyril Reboul. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat modelThe Journal of Nutritional Biochemistry 2017; 40: 95 doi: 10.1016/j.jnutbio.2016.10.012
59
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
60
Wenli Liu, Chenji Ye, Qian Cheng, Xuejiao Zhang, Liu Yao, Qi Li, Jing Huang, Yajin Liu, Zhengsheng Zou, Hua Wang, Jun Yan, Yi Zhu, Chunjiong Wang, Ding Ai. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic SteatohepatitisCellular and Molecular Gastroenterology and Hepatology 2019; 7(1): 211 doi: 10.1016/j.jcmgh.2018.09.011
61
Charlotte Brøns, Louise Groth Grunnet. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?European Journal of Endocrinology 2017; 176(2): R67 doi: 10.1530/EJE-16-0488
62
Yuhei Aotani, Yuta Kumagai, Masanobu Kameda, Kenji Wada, Toshiyuki Matsunaka, Hiroyasu Morikawa, Hiromichi Horinaka. Improvement of a combined ultrasonic probe used in ultrasonic velocity-change method for evaluation of fat contentJapanese Journal of Applied Physics 2018; 57(7S1): 07LF18 doi: 10.7567/JJAP.57.07LF18
63
Donald A. Williamson. Prevention of type 2 diabetes: what is the right target population?Expert Review of Endocrinology & Metabolism 2018; 13(6): 295 doi: 10.1080/17446651.2018.1535896
64
Wei Zhang, Samantha Chao, Stephanie Chen, Huiying Rao, Rui Huang, Lai Wei, Anna S. Lok. Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, ChinaDigestive Diseases and Sciences 2019; 64(3): 708 doi: 10.1007/s10620-018-5389-5
65
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitisCellular and Molecular Life Sciences 2016; 73(10): 1969 doi: 10.1007/s00018-016-2161-x
66
Sutapa Sarkar, Diana Kimono, Muayad Albadrani, Ratanesh K. Seth, Philip Busbee, Hasan Alghetaa, Dwayne E. Porter, Geoff I. Scott, Bryan Brooks, Mitzi Nagarkatti, Prakash Nagarkatti, Saurabh Chatterjee. Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver DiseaseScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45009-1
67
John D. Clarke, Anika Dzierlenga, Tarana Arman, Erica Toth, Hui Li, Katherine D. Lynch, Dan-Dan Tian, Michael Goedken, Mary F. Paine, Nathan Cherrington. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicityToxicon 2019; 162: 1 doi: 10.1016/j.toxicon.2019.03.002
68
O. M. Drapkina, R. N. Shepel, E. P. Yakovenko, E. V. Zyatenkova. Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver diseaseProfilakticheskaya meditsina 2019; 22(2): 82 doi: 10.17116/profmed20192202182
69
Mahmud Mahamid, Omar Abu-Elhija, Tarik Yassin, William Nseir. Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic PolypCanadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/2054871
70
Victoria Sid, Yaw L. Siow, Karmin O. Role of folate in nonalcoholic fatty liver diseaseCanadian Journal of Physiology and Pharmacology 2017; 95(10): 1141 doi: 10.1139/cjpp-2016-0681
71
Ebenezer I. O. Ajayi, Olorunfemi R. Molehin, Omotade I. Oloyede, Vinod Kumar, Venkateswara R. Amara, Jasmine Kaur, Pinakin Karpe, Kulbhushan Tikoo. Liver mitochondrial membrane permeability modulation in insulin-resistant, uninephrectomised male rats by Clerodendrum volubile P. Beauv and Manihot esculenta CrantzClinical Phytoscience 2019; 5(1) doi: 10.1186/s40816-019-0124-0
72
Brenda de Oliveira da Silva, Luciane Carla Alberici, Letícia Ferreira Ramos, Caio Mateus Silva, Marina Bonfogo da Silveira, Carlos R.P. Dechant, Scott L. Friedman, Kumiko Koibuchi Sakane, Letícia Rocha Gonçalves, Karen C.M. Moraes. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1–7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolismThe International Journal of Biochemistry & Cell Biology 2018; 98: 137 doi: 10.1016/j.biocel.2018.02.018
73
Gina Coudriet, Meghan Delmastro-Greenwood, Dana Previte, Meghan Marré, Erin O’Connor, Elizabeth Novak, Garret Vincent, Kevin Mollen, Sojin Lee, H. Dong, Jon Piganelli. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 DiabetesAntioxidants 2017; 6(4): 85 doi: 10.3390/antiox6040085
74
Jan Rozman, Birgit Rathkolb, Manuela A. Oestereicher, Christine Schütt, Aakash Chavan Ravindranath, Stefanie Leuchtenberger, Sapna Sharma, Martin Kistler, Monja Willershäuser, Robert Brommage, Terrence F. Meehan, Jeremy Mason, Hamed Haselimashhadi, Tertius Hough, Ann-Marie Mallon, Sara Wells, Luis Santos, Christopher J. Lelliott, Jacqueline K. White, Tania Sorg, Marie-France Champy, Lynette R. Bower, Corey L. Reynolds, Ann M. Flenniken, Stephen A. Murray, Lauryl M. J. Nutter, Karen L. Svenson, David West, Glauco P. Tocchini-Valentini, Arthur L. Beaudet, Fatima Bosch, Robert B. Braun, Michael S. Dobbie, Xiang Gao, Yann Herault, Ala Moshiri, Bret A. Moore, K. C. Kent Lloyd, Colin McKerlie, Hiroshi Masuya, Nobuhiko Tanaka, Paul Flicek, Helen E. Parkinson, Radislav Sedlacek, Je Kyung Seong, Chi-Kuang Leo Wang, Mark Moore, Steve D. Brown, Matthias H. Tschöp, Wolfgang Wurst, Martin Klingenspor, Eckhard Wolf, Johannes Beckers, Fausto Machicao, Andreas Peter, Harald Staiger, Hans-Ulrich Häring, Harald Grallert, Monica Campillos, Holger Maier, Helmut Fuchs, Valerie Gailus-Durner, Thomas Werner, Martin Hrabe de Angelis. Identification of genetic elements in metabolism by high-throughput mouse phenotypingNature Communications 2018; 9(1) doi: 10.1038/s41467-017-01995-2
75
Li Xue, Juntao He, Ning Gao, Xiaolan Lu, Ming Li, Xiaokang Wu, Zeshi Liu, Yaofeng Jin, Jiali Liu, Jiru Xu, Yan Geng. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemiaScientific Reports 2017; 7(1) doi: 10.1038/srep45176